AA Pharma has initiated a voluntary TYPE I recall to the Pharmacy Level for two lots (PY1829 and PY1830) of “ELAVIL FCT 10 mg”. This recall is being initiated due to one lot (PY1830) in which the acceptable intake limit for N-nitrosodimethylamine (NDMA), as established by Health Canada, has been exceeded at the 36-month stability testing timepoint. The other lot (PY1829) is being recalled as a precautionary measure since the same bulk material was used for the fabrication of both lots. Learn More
Voluntary Recall of two (2) lots of ELAVIL FCT 10 mg – Lots PY1829 and PY1830.
- January 20, 2022
